Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Sold by Point72 Asset Management L.P.

Point72 Asset Management L.P. cut its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 35.4% during the fourth quarter, HoldingsChannel.com reports. The firm owned 1,474,220 shares of the company’s stock after selling 808,590 shares during the period. Point72 Asset Management L.P.’s holdings in Acadia Healthcare were worth $58,453,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in ACHC. Lindbrook Capital LLC increased its holdings in Acadia Healthcare by 1,342.0% in the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after buying an additional 671 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after acquiring an additional 345 shares during the period. Nisa Investment Advisors LLC increased its stake in Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after purchasing an additional 301 shares in the last quarter. Signaturefd LLC raised its holdings in Acadia Healthcare by 460.6% during the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock worth $48,000 after purchasing an additional 1,004 shares during the last quarter. Finally, Fifth Third Bancorp boosted its position in Acadia Healthcare by 56.0% during the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock worth $50,000 after purchasing an additional 454 shares in the last quarter.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $25.64 on Friday. Acadia Healthcare Company, Inc. has a one year low of $20.36 and a one year high of $82.41. The company has a 50 day moving average price of $26.25 and a 200 day moving average price of $35.83. The firm has a market capitalization of $2.36 billion, a price-to-earnings ratio of 8.41, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.05. The firm had revenue of $770.51 million during the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company’s revenue was up .3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.84 EPS. Sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on ACHC shares. Mizuho dropped their price target on Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating for the company in a research report on Wednesday. Guggenheim initiated coverage on shares of Acadia Healthcare in a research report on Wednesday, April 9th. They set a “buy” rating and a $36.00 target price for the company. Royal Bank of Canada lowered their price target on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a research report on Monday, March 3rd. Bank of America dropped their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research note on Friday, February 28th. Finally, KeyCorp reduced their target price on Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating on the stock in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, Acadia Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $47.94.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.